| 000 | 01773 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517111023.0 | ||
| 264 | 0 | _c20170324 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1096-0295 | ||
| 024 | 7 |
_a10.1016/j.yrtph.2016.08.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTien, Chin-Chieh | |
| 245 | 0 | 0 |
_aSlow infusion rate of doxorubicin induces higher pro-inflammatory cytokine production. _h[electronic resource] |
| 260 |
_bRegulatory toxicology and pharmacology : RTP _cNov 2016 |
||
| 300 |
_a69-76 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCardiotoxicity |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Diseases _xblood |
| 650 | 0 | 4 |
_aInflammation _xblood |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xblood |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aPeng, Yi-Chi | |
| 700 | 1 | _aYang, Fwu-Lin | |
| 700 | 1 | _aSubeq, Yi-Maun | |
| 700 | 1 | _aLee, Ru-Ping | |
| 773 | 0 |
_tRegulatory toxicology and pharmacology : RTP _gvol. 81 _gp. 69-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yrtph.2016.08.002 _zAvailable from publisher's website |
| 999 |
_c26300986 _d26300986 |
||